News | ACC | March 21, 2024

Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)

Association Between Prognostic Implications of Platelet FCɣRIIA (PFCG) and Treatment Strategy for Myocardial Infarction

Getty Images


March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal of predicting the risk of thrombosis by quantifying platelet FcγRIIa (pFCG test), announced the acceptance of its abstract titled Association Between Prognostic Implications of Platelet FCɣRIIA (PFCG) and Treatment Strategy for Myocardial Infarction at The American College of Cardiology (ACC) Scientific Sessions 2024 in Atlanta.

Co-Founder and Chief Science Officer David J. Schneider, MD, FACC FAHA said “I look forward to presenting these compelling results at ACC 24 to colleagues from around the world and I thank those that are participating in our ongoing clinical program.”

“We are honored to be a part of ACC 24 and to join the conversation on the latest science and innovations in this space. Individualized antiplatelet therapy is becoming a critical issue for patient care and we are excited to be leading the way,” said Pete DiBattiste, MD, FACC, FAHA, co-Founder and CEO of Prolocor.

For more information: www.prolocor.com

Find more ACC24 conference coverage here


Related Content

News | Cardiovascular Education

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
Feature | Cardiovascular Education | Christine Book

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
News | Cardiovascular Education

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
News | Cardiovascular Education

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home December 04, 2023
Home
News | Cardiovascular Education

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
News | Cardiovascular Education

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Home August 16, 2023
Home
Feature | Cardiovascular Education | Christine Book

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute ...

Home May 04, 2023
Home
News | Cardiovascular Education

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

Home April 10, 2023
Home
News | Cardiovascular Education

April 4, 2023 — Harding University has announced it will offer a new degree format for its Master of Science in cardiac ...

Home April 04, 2023
Home
News | Cardiovascular Education

March 30, 2023 — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new ...

Home March 30, 2023
Home
Subscribe Now